Hemoglobin

FDA Approves First Gene Therapy Offering New Hope for Sickle Cell Disease

The U.S. Food and Drug Administration has approved a landmark gene therapy for sickle cell disease, marking a major advance in the treatment of a painful inherited blood disorder that affects…